Skip to main content
M1 Kliniken AG logo

M1 Kliniken AG — Investor Relations & Filings

Ticker · M12 ISIN · DE000A0STSQ8 LEI · 529900W697S31A26WT02 F Human health and social work activities
Open in API
Filings indexed 165 across all filing types
Latest filing 2025-04-29 Earnings Release
Country DE Germany
Listing F M12

About M1 Kliniken AG

https://www.m1-kliniken.de/en/index.html

M1 Kliniken AG is a provider of health services in the beauty sector, specializing in aesthetic medicine and plastic surgery. The company operates a chain of specialized medical centers offering a range of treatments, including non-surgical procedures like wrinkle and lip treatments, as well as surgical interventions such as breast corrections. The core of its business model is to provide affordable access to aesthetic treatments while maintaining high quality standards. In addition to its clinical services, the company also offers a portfolio of beauty products.

Recent filings

Filing Released Lang Actions
M1 Kliniken AG publishes preliminary figures for the 2024 financial year: Strong EBIT growth (+70%) and significant increase in earnings per share (+57%)
Earnings Release Classification · 100% confidence The document explicitly states it publishes "preliminary IFRS consolidated figures for the 2024 financial year." It provides key financial metrics (Revenue, EBITDA, EBIT, EPS) for a full fiscal year, which strongly suggests a full annual result disclosure. However, the title and content emphasize that these are *preliminary* figures, and the document is structured as a news release announcing these results, rather than the comprehensive, audited 10-K filing itself. Furthermore, the document is short (5259 chars) and ends with a standard EQS news dissemination footer, indicating it is an announcement of results. This fits the definition of an Earnings Release (ER), which covers periodical financial results (in this case, the full year's preliminary results). While it contains annual data, it is the initial announcement, not the final 10-K. FY 2024
2025-04-29 English
Konzernabschluss zum Geschäftsjahr vom 01.01.2023 bis zum 31.12.2023
Annual Report Classification · 100% confidence The document is a comprehensive annual report for M1 Kliniken AG for the fiscal year 2023. It includes the 'Bericht des Aufsichtsrates' (Supervisory Board Report), detailed business segments, and economic analysis. It is clearly a full annual report rather than an announcement or a summary, as it contains substantive financial and operational disclosures. FY 2023
2025-04-03 German
M1 Kliniken AG: HAEMATO AG is reviewing an offer for the sale of its trading segment
M&A Activity Classification · 99% confidence The document is an 'Ad-hoc' disclosure dated April 1, 2025, issued under Article 17 of the EU Market Abuse Regulation (MAR). It announces that HAEMATO AG (majority-owned by M1 Kliniken AG) has received a Conditional Binding Offer (CBO) for the sale of its trading segment and that the Boards are reviewing it. This type of announcement concerns a potential major corporate transaction (M&A activity) or a significant strategic change, but it is not the final definitive agreement or a standard periodic report. Since the core subject is a proposal for the acquisition/sale of a business segment, it aligns best with the M&A Activity category (TAR). It is not a standard regulatory filing like 10-K or IR, nor is it a general regulatory announcement (RNS) as it concerns a specific, material corporate event.
2025-04-01 English
Jahresabschluss zum Geschäftsjahr vom 01.01.2023 bis zum 31.12.2023
Audit Report / Information Classification · 98% confidence The document is a formal 'Jahresabschluss' (Annual Financial Statement) for M1 Kliniken AG for the fiscal year 2023. It contains a balance sheet (Bilanz), notes to the financial statements (Anhang), and details regarding the appropriation of profits. While it is not the full 10-K (which typically includes extensive management discussion and analysis in a specific regulatory format), it serves as the primary annual financial reporting document for the company under German commercial law (HGB). Given the options provided, it is best classified as an Annual Report (10-K) as it represents the official yearly financial performance report. FY 2023
2025-01-27 German
M1 Kliniken AG increases operating profit (EBIT) by 71% in the first nine months of 2024 and confirms medium-term targets
Earnings Release Classification · 100% confidence The document is a news release dated November 19, 2024, reporting financial performance for the 'first nine months of 2024'. It highlights key metrics like sales, EBIT, and net profit, and confirms medium-term targets. The presence of 'Quarter Results/9 Month figures' as a keyword and the detailed summary of performance over a nine-month period strongly indicate this is an announcement of interim financial results, rather than the full annual report (10-K) or a comprehensive interim report (IR). Since it is an initial announcement of key results, it fits the definition of an Earnings Release (ER). The document is short and appears to be the release itself, not just an announcement of a larger report. 9M 2024
2024-11-19 English
Half-yearly financial statements 2024
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM REPORT 2024' and contains comprehensive financial statements (Consolidated Profit and Loss Account, Balance Sheet), management discussion and analysis (Group Interim Management Report), and notes to the financial statements for the period ending 30.06.2024. It is a full financial report for a period shorter than a fiscal year, fitting the definition of an Interim/Quarterly Report. H1 2024
2024-10-24 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.